Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

NSAIDs and Colorectal Cancer Phenotypes: What Now?

Barry EL, Fedirko V, Baron JA.

J Natl Cancer Inst. 2018 Nov 2. doi: 10.1093/jnci/djy174. [Epub ahead of print] No abstract available.

PMID:
30388268
2.

Effects of Supplemental Calcium and Vitamin D on Expression of Toll-Like Receptors and Phospho-IKKα/β in the Normal Rectal Mucosa of Colorectal Adenoma Patients.

Hodge R, Mandle HB, Ray S, Tandon S, Peterson M, Henry A, Jahan FA, Bostick RM, Baron JA, Barry EL, Yacoub R, Rutherford RE, Seabrook ME, Fedirko V.

Cancer Prev Res (Phila). 2018 Nov;11(11):707-716. doi: 10.1158/1940-6207.CAPR-18-0123. Epub 2018 Sep 12.

PMID:
30209117
3.

Body mass index, calcium supplementation and risk of colorectal adenomas.

Barry EL, Lund JL, Westreich D, Mott LA, Ahnen DJ, Beck GJ, Bostick RM, Bresalier RS, Burke CA, Church TR, Rees JR, Robertson DJ, Baron JA.

Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31803. [Epub ahead of print]

PMID:
30117164
4.

Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Qu C, Melas M, Van Den Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D, Alonso MH, Amos CI, Anton K, Aragaki AK, Arndt V, Barry EL, Berndt SI, Bezieau S, Bien S, Bloomer A, Boehm J, Boutron-Ruault MC, Brenner H, Brezina S, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castelao JE, Chan AT, Chang-Claude J, Chanock SJ, Cheng I, Cheng YW, Chin LS, Church JM, Church T, Coetzee GA, Cotterchio M, Cruz Correa M, Curtis KR, Duggan D, Easton DF, English D, Feskens EJM, Fischer R, FitzGerald LM, Fortini BK, Fritsche LG, Fuchs CS, Gago-Dominguez M, Gala M, Gallinger SJ, Gauderman WJ, Giles GG, Giovannucci EL, Gogarten SM, Gonzalez-Villalpando C, Gonzalez-Villalpando EM, Grady WM, Greenson JK, Gsur A, Gunter M, Haiman CA, Hampe J, Harlid S, Harju JF, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Huang SC, Huerta JM, Hudson TJ, Hunter DJ, Idos GE, Iwasaki M, Jackson RD, Jacobs EJ, Jee SH, Jenkins MA, Jia WH, Jiao S, Joshi AD, Kolonel LN, Kono S, Kooperberg C, Krogh V, Kuehn T, Küry S, LaCroix A, Laurie CA, Lejbkowicz F, Lemire M, Lenz HJ, Levine D, Li CI, Li L, Lieb W, Lin Y, Lindor NM, Liu YR, Loupakis F, Lu Y, Luh F, Ma J, Mancao C, Manion FJ, Markowitz SD, Martin V, Matsuda K, Matsuo K, McDonnell KJ, McNeil CE, Milne R, Molina AJ, Mukherjee B, Murphy N, Newcomb PA, Offit K, Omichessan H, Palli D, Cotoré JPP, Pérez-Mayoral J, Pharoah PD, Potter JD, Qu C, Raskin L, Rennert G, Rennert HS, Riggs BM, Schafmayer C, Schoen RE, Sellers TA, Seminara D, Severi G, Shi W, Shibata D, Shu XO, Siegel EM, Slattery ML, Southey M, Stadler ZK, Stern MC, Stintzing S, Taverna D, Thibodeau SN, Thomas DC, Trichopoulou A, Tsugane S, Ulrich CM, van Duijnhoven FJB, van Guelpan B, Vijai J, Virtamo J, Weinstein SJ, White E, Win AK, Wolk A, Woods M, Wu AH, Wu K, Xiang YB, Yen Y, Zanke BW, Zeng YX, Zhang B, Zubair N, Kweon SS, Figueiredo JC, Zheng W, Marchand LL, Lindblom A, Moreno V, Peters U, Casey G, Hsu L, Conti DV, Gruber SB.

J Natl Cancer Inst. 2018 Jun 16. doi: 10.1093/jnci/djy099. [Epub ahead of print]

PMID:
29917119
5.

Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.

Passarelli MN, Barry EL, Zhang D, Gangar P, Rees JR, Bresalier RS, McKeown-Eyssen G, Karagas MR, Baron JA.

Br J Dermatol. 2018 Aug;179(2):337-344. doi: 10.1111/bjd.16571. Epub 2018 Jun 19.

PMID:
29570772
6.

Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial.

Crockett SD, Barry EL, Mott LA, Ahnen DJ, Robertson DJ, Anderson JC, Wallace K, Burke CA, Bresalier RS, Figueiredo JC, Snover DC, Baron JA.

Gut. 2018 Mar 1. pii: gutjnl-2017-315242. doi: 10.1136/gutjnl-2017-315242. [Epub ahead of print]

PMID:
29496722
7.

Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?

Anderson JC, Morris CB, Robertson DJ, Barry ELR, Figueiredo JC, Cruz-Correa M, Bostick RM, Ahnen DJ, Baron JA.

J Clin Gastroenterol. 2018 Aug;52(7):628-634. doi: 10.1097/MCG.0000000000000899.

PMID:
28767463
8.

Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk.

Rees JR, Morris CB, Peacock JL, Ueland PM, Barry EL, McKeown-Eyssen GE, Figueiredo JC, Snover DC, Baron JA.

Cancer Prev Res (Phila). 2017 Aug;10(8):451-458. doi: 10.1158/1940-6207.CAPR-16-0278. Epub 2017 Jun 9.

9.

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ.

Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20.

PMID:
28219690
10.

Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas.

Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA.

Mol Carcinog. 2017 Aug;56(8):1977-1983. doi: 10.1002/mc.22629. Epub 2017 Mar 6.

11.

Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial.

Barry EL, Peacock JL, Rees JR, Bostick RM, Robertson DJ, Bresalier RS, Baron JA.

JAMA Oncol. 2017 May 1;3(5):628-635. doi: 10.1001/jamaoncol.2016.5917.

12.

Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults.

Rees JR, Mott LA, Barry EL, Baron JA, Bostick RM, Figueiredo JC, Bresalier RS, Robertson DJ, Peacock JL.

J Nutr. 2016 Nov;146(11):2312-2324. Epub 2016 Sep 28.

13.

Randomized controlled trials: who fails run-in?

Rees JR, Mott LA, Barry EL, Baron JA, Figueiredo JC, Robertson DJ, Bresalier RS, Peacock JL.

Trials. 2016 Jul 29;17:374. doi: 10.1186/s13063-016-1451-9.

14.

Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients.

Liu S, Barry EL, Baron JA, Rutherford RE, Seabrook ME, Bostick RM.

Mol Carcinog. 2017 Feb;56(2):412-424. doi: 10.1002/mc.22504. Epub 2016 Jun 14.

15.

Association between adenoma location and risk of recurrence.

Pohl H, Robertson DJ, Mott LA, Ahnen DJ, Burke CA, Barry EL, Bresalier RS, Figueiredo JC, Shaukat A, Sandler RS, Baron JA.

Gastrointest Endosc. 2016 Oct;84(4):709-16. doi: 10.1016/j.gie.2016.02.048. Epub 2016 Mar 11.

16.

Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Ivanova A.

N Engl J Med. 2016 Feb 25;374(8):791-2. doi: 10.1056/NEJMc1514501. No abstract available.

17.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW.

N Engl J Med. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409.

18.

Risk Factors for Hemorrhoids on Screening Colonoscopy.

Peery AF, Sandler RS, Galanko JA, Bresalier RS, Figueiredo JC, Ahnen DJ, Barry EL, Baron JA.

PLoS One. 2015 Sep 25;10(9):e0139100. doi: 10.1371/journal.pone.0139100. eCollection 2015.

19.

Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).

Fedirko V, Bradshaw PT, Figueiredo JC, Sandler RS, Barry EL, Ahnen DJ, Milne GL, Bresalier RS, Baron JA.

Cancer Prev Res (Phila). 2015 Nov;8(11):1061-8. doi: 10.1158/1940-6207.CAPR-15-0212. Epub 2015 Aug 24.

20.

The association of age and race and the risk of large bowel polyps.

Wallace K, Burke CA, Ahnen DJ, Barry EL, Bresalier RS, Saibil F, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):448-53. doi: 10.1158/1055-9965.EPI-14-1076. Epub 2014 Dec 9.

21.

Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.

Fortini BK, Tring S, Plummer SJ, Edlund CK, Moreno V, Bresalier RS, Barry EL, Church TR, Figueiredo JC, Casey G.

PLoS One. 2014 Nov 6;9(11):e111914. doi: 10.1371/journal.pone.0111914. eCollection 2014.

22.

Calcium supplementation increases blood creatinine concentration in a randomized controlled trial.

Barry EL, Mott LA, Melamed ML, Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA.

PLoS One. 2014 Oct 15;9(10):e108094. doi: 10.1371/journal.pone.0108094. eCollection 2014.

23.

C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study.

Crockett SD, Mott LA, Barry EL, Figueiredo JC, Burke CA, Baxter GJ, Sandler RS, Baron JA.

Cancer Prev Res (Phila). 2014 Nov;7(11):1122-7. doi: 10.1158/1940-6207.CAPR-14-0167. Epub 2014 Aug 21.

24.

Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.

Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2133-7. doi: 10.1210/jc.2014-1389. Epub 2014 Jul 29.

25.

Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.

Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, Barry EL, Berman BP, Rice JC, Coetzee GA, Casey G.

Hum Mol Genet. 2014 Apr 15;23(8):2198-209. doi: 10.1093/hmg/ddt584. Epub 2013 Nov 20.

26.

Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial.

Rees JR, Hendricks K, Barry EL, Peacock JL, Mott LA, Sandler RS, Bresalier RS, Goodman M, Bostick RM, Baron JA.

Clin Infect Dis. 2013 Nov;57(10):1384-92. doi: 10.1093/cid/cit549. Epub 2013 Sep 6.

27.

Constipation and a low-fiber diet are not associated with diverticulosis.

Peery AF, Sandler RS, Ahnen DJ, Galanko JA, Holm AN, Shaukat A, Mott LA, Barry EL, Fried DA, Baron JA.

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1622-7. doi: 10.1016/j.cgh.2013.06.033. Epub 2013 Jul 23.

28.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM.

Cancer Causes Control. 2013 Jan;24(1):47-54. doi: 10.1007/s10552-012-0088-6. Epub 2012 Oct 19.

29.

Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.

Barry EL, Mott LA, Sandler RS, Ahnen DJ, Baron JA.

Cancer Prev Res (Phila). 2011 Dec;4(12):2072-82. doi: 10.1158/1940-6207.CAPR-11-0300. Epub 2011 Sep 19.

30.

Serum salicylate levels and risk of recurrent colorectal adenomas.

Shaukat A, Grau MV, Church TR, Baxter G, Barry EL, Summers R, Sandler RS, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):679-82. doi: 10.1158/1055-9965.EPI-10-1135. Epub 2011 Feb 9.

31.

Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.

Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, Gui J, Haile RW, Barry EL, Ahnen D, McKeown-Eyssen G, Baron JA, Issa JP.

Cancer Prev Res (Phila). 2010 Dec;3(12):1552-64. doi: 10.1158/1940-6207.CAPR-10-0047.

32.

Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.

Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Barry EL, Saibil F, Bresalier RS, Rohan TE, Baron JA.

J Natl Cancer Inst. 2009 Dec 2;101(23):1650-4. doi: 10.1093/jnci/djp346. Epub 2009 Oct 12.

33.

Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.

Barry EL, Sansbury LB, Grau MV, Ali IU, Tsang S, Munroe DJ, Ahnen DJ, Sandler RS, Saibil F, Gui J, Bresalier RS, McKeown-Eyssen GE, Burke C, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2726-33. doi: 10.1158/1055-9965.EPI-09-0363. Epub 2009 Sep 15.

34.

The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.

Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, Gui J, Barry EL, Summers RW, McKeown-Eyssen G, Haile RW, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2310-7. doi: 10.1158/1055-9965.EPI-09-0211.

35.

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):267-76. doi: 10.1093/jnci/djn484. Epub 2009 Feb 10.

36.

Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.

Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2625-31. doi: 10.1158/1055-9965.EPI-08-0382.

37.

MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.

Levine AJ, Wallace K, Tsang S, Haile RW, Saibil F, Ahnen D, Cole BF, Barry EL, Munroe DJ, Ali IU, Ueland P, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2409-15. doi: 10.1158/1055-9965.EPI-07-2670.

38.

Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.

Figueiredo JC, Levine AJ, Grau MV, Midttun O, Ueland PM, Ahnen DJ, Barry EL, Tsang S, Munroe D, Ali I, Haile RW, Sandler RS, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2136-45. doi: 10.1158/1055-9965.EPI-07-2895.

39.

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER; Polyp Prevention Study Group.

JAMA. 2007 Jun 6;297(21):2351-9.

PMID:
17551129
40.

Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.

Grau MV, Baron JA, Sandler RS, Wallace K, Haile RW, Church TR, Beck GJ, Summers RW, Barry EL, Cole BF, Snover DC, Rothstein R, Mandel JS.

J Natl Cancer Inst. 2007 Jan 17;99(2):129-36.

PMID:
17227996
41.

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.

Barry EL, Baron JA, Bhat S, Grau MV, Burke CA, Sandler RS, Ahnen DJ, Haile RW, O'Brien TG.

J Natl Cancer Inst. 2006 Oct 18;98(20):1494-500. Erratum in: J Natl Cancer Inst. 2006 Dec 20;98(24):1828.

PMID:
17047198
42.

K-ras mutations in incident sporadic colorectal adenomas.

Barry EL, Baron JA, Grau MV, Wallace K, Haile RW.

Cancer. 2006 Mar 1;106(5):1036-40.

43.

Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.

Grau MV, Baron JA, Barry EL, Sandler RS, Haile RW, Mandel JS, Cole BF.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2353-8.

45.

Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.

Sneddon WB, Barry EL, Coutermarsh BA, Gesek FA, Liu F, Friedman PA.

Cell Physiol Biochem. 1998;8(5):261-77.

46.
47.

Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics.

Barry EL, Gesek FA, Kaplan MR, Hebert SC, Friedman PA.

Am J Physiol. 1997 Jan;272(1 Pt 1):C109-16.

PMID:
9038817
48.

Antisense oligodeoxynucleotide inhibition of a swelling-activated cation channel in osteoblast-like osteosarcoma cells.

Duncan RL, Kizer N, Barry EL, Friedman PA, Hruska KA.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1864-9.

49.

Multiple calcium channel transcripts in rat osteosarcoma cells: selective activation of alpha 1D isoform by parathyroid hormone.

Barry EL, Gesek FA, Froehner SC, Friedman PA.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10914-8.

50.

Expression and antibody inhibition of P-type calcium channels in human small-cell lung carcinoma cells.

Barry EL, Viglione MP, Kim YI, Froehner SC.

J Neurosci. 1995 Jan;15(1 Pt 1):274-83.

Supplemental Content

Loading ...
Support Center